Lianyungang, China

Xiaoheng Zhang

This inventor holds 9 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Scinopharm Taiwan, Ltd., Scinopharm (Changshu) Pharmaceuticals, Ltd., Scinopharm (Kunshan) Biochemical Technology Co., Ltd.. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoheng Zhang. Retrieved from https://idiyas.com/inventor/xiaoheng-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7



Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Kunshan, CN (2012)
  • Lianyungang, CN (2012 - 2013)
  • Lianyungana, CN (2014)
  • Changshu, CN (2013 - 2017)
  • Jiangsu, CN (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Xiaoheng Zhang - Innovative Inventor from Lianyungang

Introduction: Xiaoheng Zhang is a talented inventor hailing from Lianyungang, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xiaoheng Zhang holds several patents in various technological domains, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: Throughout his illustrious career, Xiaoheng Zhang has worked on numerous projects that have revolutionized the industry, earning him a reputation as a visionary inventor.

Collaborations: Xiaoheng Zhang has collaborated with leading research institutions, universities, and tech companies, pooling his expertise to create cutting-edge solutions that have a lasting impact on the world of technology.

Conclusion: Xiaoheng Zhang's relentless pursuit of innovation and his passion for creating transformative technologies make him a standout figure in the realm of inventors, inspiring the next generation of innovators to dream big and push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…